These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21294702)

  • 1. Pharmacotherapy and prevention of vascular dementia.
    Moretti A; Gorini A; Villa RF
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):370-90. PubMed ID: 21294702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular dementia: distinguishing characteristics, treatment, and prevention.
    Román GC
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S296-304. PubMed ID: 12801386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection in vascular dementia.
    Martínez-Vila E; Murie-Fernández M; Gállego Pérez-Larraya J; Irimia P
    Cerebrovasc Dis; 2006; 21 Suppl 2():106-17. PubMed ID: 16651821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular dementia. Advances in nosology, diagnosis, treatment and prevention.
    Román GC
    Panminerva Med; 2004 Dec; 46(4):207-15. PubMed ID: 15876977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options and considerations for hypertensive patients to prevent dementia.
    Hernandorena I; Duron E; Vidal JS; Hanon O
    Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facts, myths, and controversies in vascular dementia.
    Román GC
    J Neurol Sci; 2004 Nov; 226(1-2):49-52. PubMed ID: 15537519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
    Farlow MR
    Mayo Clin Proc; 2006 Oct; 81(10):1350-8. PubMed ID: 17036561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine in the treatment of vascular dementia.
    Brashear HR
    Int Psychogeriatr; 2003; 15 Suppl 1():187-93. PubMed ID: 16191239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular dementia -- diagnosis, prevention and treatment].
    Wolf H; Gertz HJ
    Psychiatr Prax; 2004 Oct; 31(7):330-8. PubMed ID: 15467961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic issues in vascular dementia: studies, designs and approaches.
    Black SE
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S125-30. PubMed ID: 17474183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cognitive impairment.
    Bowler JV
    Stroke; 2004 Feb; 35(2):386-8. PubMed ID: 14757888
    [No Abstract]   [Full Text] [Related]  

  • 16. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives.
    Baskys A; Cheng JX
    Exp Gerontol; 2012 Nov; 47(11):887-91. PubMed ID: 22796225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB
    CNS Drugs; 2017 Sep; 31(9):759-776. PubMed ID: 28786085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for vascular dementia and vascular cognitive impairment.
    Erkinjuntti T; Román G; Gauthier S; Feldman H; Rockwood K
    Stroke; 2004 Apr; 35(4):1010-7. PubMed ID: 15001795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of mixed dementia.
    Zekry D; Gold G
    Drugs Aging; 2010 Sep; 27(9):715-28. PubMed ID: 20809662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.